How repeatable is new visual field test?
Not Applicable
Completed
- Conditions
- Health Condition 1: H409- Unspecified glaucoma
- Registration Number
- CTRI/2020/10/028348
- Lead Sponsor
- MAHE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 230
Inclusion Criteria
Glaucoma participants: Early to advance glaucoma (Optic nerve damage, SAP reports indicating VF
defects)
Normal participants: Diagnosed healthy eyes
Best Corrected Visual Acuity (BCVA) of 0.1 logMAR or better
Refractive error between ± 6.00 DS equivalent and cylindrical correction within ± 3.00 DC
Exclusion Criteria
Glaucoma participants: Systemic diseases known to affect retina. Retinal pathology other than glaucoma. High progression of visual field damage.
Normal participants: Any ocular pathology other than cataract. Systemic diseases affecting visual function or retina. Under any medication that affects vision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method